产品介绍
猫白血病是猫常见的非创伤性致死疾病,是由猫白血病病毒和猫肉瘤病毒引起的恶性肿瘤性传染病。主要特征是恶性淋巴肿瘤、骨髓性白血病以及变性性胸腺萎缩和非再生性贫血等,其中对猫最严重的是恶性淋巴肿瘤。幼猫易感性高,随年龄增长易感性降低。
|
产品名称
|
类型
|
货号
|
来源
|
建议使用
|
应用
|
|
FLV66
|
rAg
|
|
E.coli
|
包被/标记
|
EIA、LF
|
【仅供科学研究使用】
相关产品:
| 产品名称 |
点击数 |
| Anti-Mouse CD248 Recombinant Antibody, APC|抗小鼠CD248重组抗体,APC(靶标:小鼠CD248(Endosialin)) |
283 |
| Anti-Human CD209 Recombinant Antibody, APC|抗人CD209重组抗体,APC(靶标:人CD209(DC-SIGN)) |
129 |
| Anti-Human CD266/TNFRSF12A Recombinant Antibody , APC|抗人CD266/TNFRSF12A重组抗体,APC(靶标:人TWEAK受体(TNFRSF12A)) |
436 |
| Anti-Human CD354/TREM1 Recombinant Antibody, APC|抗人CD354/TREM1重组抗体,APC(靶标:人髓系细胞触发受体1) |
147 |
| Anti-Human IL23A Recombinant Antibody , APC|抗人IL23A重组抗体,APC(靶标:人IL-23 p19亚基) |
441 |
| Anti-Human IL23A Recombinant Antibody , APC|抗人IL23A重组抗体,APC(靶标:人IL-23 p19亚基) |
126 |
| Anti-Human IL1RAP Recombinant Antibody , APC|抗人IL1RAP重组抗体,APC(靶标:人IL-1受体辅助蛋白) |
327 |
| Anti-Human CD93/C1qR Recombinant Antibody, APC|抗人CD93/C1qR重组抗体,APC(靶标:人CD93(C1qR)) |
381 |
| Anti-Human CD93/C1qR Recombinant Antibody, APC|抗人CD93/C1qR重组抗体,APC(靶标:人CD93(C1qR)) |
409 |
| Anti-Human CD319/SLAMF7 Recombinant Antibody, APC|抗人CD319/SLAMF7重组抗体,APC(靶标:人SLAMF7(CD319)) |
399 |
| Anti-Human CD319/SLAMF7 Recombinant Antibody, APC|抗人CD319/SLAMF7重组抗体,APC(靶标:人SLAMF7(CD319)) |
276 |
| Anti-Human DLL4 Recombinant Antibody , APC|抗人DLL4重组抗体,APC(靶标:人Delta样配体4) |
434 |
| Anti-Human DLL4 Recombinant Antibody , APC|抗人DLL4重组抗体,APC(靶标:人Delta样配体4) |
461 |
| Anti-Mouse DLL4 Recombinant Antibody, APC|抗小鼠DLL4重组抗体,APC(靶标:小鼠Delta样配体4) |
501 |
| Anti-Human PDGFC Recombinant Antibody , APC|抗人PDGFC重组抗体,APC(靶标:人血小板衍生生长因子C) |
236 |
| Anti-Human FGF21 Recombinant Antibody , APC|抗人FGF21重组抗体,APC(靶标:人成纤维细胞生长因子21) |
320 |
| Anti-Human IL20 Recombinant Antibody , APC|抗人IL20重组抗体,APC(靶标:人白细胞介素-20) |
384 |
| Anti-Human TREM2 Recombinant Antibody , APC|抗人TREM2重组抗体,APC(靶标:人髓系细胞触发受体2) |
466 |
| Anti-Human CD274/PD-L1/B7-H1 Recombinant Antibody , APC|抗人CD274/PD-L1/B7-H1重组抗体,APC(靶标:人PD-L1) |
290 |
| Anti-Human CD274/PD-L1/B7-H1 Recombinant Antibody, APC|抗人CD274/PD-L1/B7-H1重组抗体,APC(靶标:人PD-L1) |
312 |